中外医学研究
中外醫學研究
중외의학연구
Chinese and Foreign Medical Research
2015年
31期
22-23
,共2页
支气管哮喘%孟鲁司特钠%布地奈德
支氣管哮喘%孟魯司特鈉%佈地奈德
지기관효천%맹로사특납%포지내덕
Bronchial asthma%Montelukast%Budesonide
目的：对孟鲁司特钠、布地奈德联合治疗支气管哮喘的临床疗效进行评价。方法：选择2014年6月-2015年6月笔者所在医院收治的60例支气管哮喘患儿作为观察对象，按照随机数字表法分为两组。对照组予常规对症治疗，观察组在对照组基础上加用孟鲁司特钠、布地奈德，观察比较两组患儿治疗后的总有效率和咳嗽、喘息及哮鸣音消失时间。结果：观察组治疗后的总有效率为93.3%，高于对照组的70.0%，两组疗效比较差异有统计学意义(P<0.05)。观察组患儿咳嗽、喘息及哮鸣音消失时间均短于对照组，差异均有统计学意义(P<0.05)。结论：在常规对症治疗支气管哮喘的同时加用孟鲁司特钠、布地奈德，可以提高疗效，有效缓解患者的临床症状，值得推广和应用。
目的：對孟魯司特鈉、佈地奈德聯閤治療支氣管哮喘的臨床療效進行評價。方法：選擇2014年6月-2015年6月筆者所在醫院收治的60例支氣管哮喘患兒作為觀察對象，按照隨機數字錶法分為兩組。對照組予常規對癥治療，觀察組在對照組基礎上加用孟魯司特鈉、佈地奈德，觀察比較兩組患兒治療後的總有效率和咳嗽、喘息及哮鳴音消失時間。結果：觀察組治療後的總有效率為93.3%，高于對照組的70.0%，兩組療效比較差異有統計學意義(P<0.05)。觀察組患兒咳嗽、喘息及哮鳴音消失時間均短于對照組，差異均有統計學意義(P<0.05)。結論：在常規對癥治療支氣管哮喘的同時加用孟魯司特鈉、佈地奈德，可以提高療效，有效緩解患者的臨床癥狀，值得推廣和應用。
목적：대맹로사특납、포지내덕연합치료지기관효천적림상료효진행평개。방법：선택2014년6월-2015년6월필자소재의원수치적60례지기관효천환인작위관찰대상，안조수궤수자표법분위량조。대조조여상규대증치료，관찰조재대조조기출상가용맹로사특납、포지내덕，관찰비교량조환인치료후적총유효솔화해수、천식급효명음소실시간。결과：관찰조치료후적총유효솔위93.3%，고우대조조적70.0%，량조료효비교차이유통계학의의(P<0.05)。관찰조환인해수、천식급효명음소실시간균단우대조조，차이균유통계학의의(P<0.05)。결론：재상규대증치료지기관효천적동시가용맹로사특납、포지내덕，가이제고료효，유효완해환자적림상증상，치득추엄화응용。
Objective:To evaluate the clinical efficacy of Montelukast combined with Budesonide in the treatment of bronchial asthma. Method:60 cases of bronchial asthma treated in our hospital from June 2015 to June 2014 were randomly divided into two groups.The patients in control group were treated with conventional symptomatic treatment,the observation group on the basis of the control group was given Sodium Montelukast combined with Budesonide,the total efficiency was observed and compared after treatment in two groups,and the coughing,wheezing and wheezing in singing disappearance time were compared between two groups.Result:The total effective rate of the observation group was 93.3%,it was higher than 70.0% of the control group,the efficacy of two groups were compared,the difference was statistically significant(P<0.05).The cough,wheezing and wheezing disappearance time of the observation group were shorter than those of the control group(P<0.05).Conclusion:The conventional symptomatic treatment combined with Sodium Montelukast and Budesonide in the treatment of bronchial asthma,can improve the curative effect,effectively relieve the clinical symptoms,is worth of popularization and application.
